Revance Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $183k | 21k | 8.80 |
| 2023-09-30 | $155k | 14k | 11.48 |
| 2023-06-30 | $342k | 14k | 25.33 |
| 2023-03-31 | $364k | 11k | 32.21 |
| 2022-12-31 | $209k | 11k | 18.50 |
| 2022-09-30 | $256k | 9.5k | 26.95 |
| 2021-12-31 | $263k | 16k | 16.34 |
| 2021-09-30 | $449k | 16k | 27.89 |
| 2021-06-30 | $477k | 16k | 29.63 |